These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31526711)

  • 1. Automating Vancomycin Monitoring to Improve Patient Safety.
    Mishra V; Chouinard M; Keiser J; Wagner B; Yen MS; Banas C; Dow A
    Jt Comm J Qual Patient Saf; 2019 Nov; 45(11):757-762. PubMed ID: 31526711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approach to vancomycin level monitoring: Impact of a multidisciplinary monitoring system on timing of vancomycin levels.
    Peyko V; Friedman-Jakubovics M
    Am J Health Syst Pharm; 2018 Feb; 75(3):121-126. PubMed ID: 29371192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Pediatric-Specific Vancomycin Dosing Guidelines: A Quality Improvement Initiative.
    Miloslavsky M; Galler MF; Moawad I; Actis J; Cummings BM; El Saleeby CM
    Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.
    Hammond DA; James TB; Atkinson LN; Painter JT; Lusardi K
    Crit Care Nurse; 2018 Feb; 38(1):24-28. PubMed ID: 29437075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring.
    Kabbara WK; El-Khoury G; Chamas NR
    J Infect Dev Ctries; 2018 Nov; 12(11):978-984. PubMed ID: 32012127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.
    Thomas CA; Picone A; Menon S; Willis BC
    Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Outcome of Pharmacy-Led Vancomycin Dosing and Monitoring.
    Momattin H; Zogheib M; Homoud A; Al-Tawfiq JA
    Chemotherapy; 2016; 61(1):3-7. PubMed ID: 26555724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the correct timing of vancomycin level collection utilizing a vancomycin medication administration record (MAR) level order.
    Shah S; Rouse GE; McManus D; Tichy EM; DeVaux L; Hutchins L; Topal JE
    Int J Med Inform; 2020 Nov; 143():104249. PubMed ID: 32957015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of a divided-load intravenous vancomycin dosing strategy for obese patients.
    Denetclaw TH; Yu MK; Moua M; Dowling TC; Steinke D
    Ann Pharmacother; 2015 Aug; 49(8):861-8. PubMed ID: 25986008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.
    Davis SL; Scheetz MH; Bosso JA; Goff DA; Rybak MJ
    Pharmacotherapy; 2013 Dec; 33(12):1256-63. PubMed ID: 23897602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J; Levkovich BJ; Padiglione AA
    Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Nursing Education on the Proportion of Appropriately Drawn Vancomycin Trough Concentrations.
    Coleman LK; Wilson AS
    J Pharm Pract; 2016 Oct; 29(5):472-4. PubMed ID: 25613053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin trough concentrations in overweight or obese pediatric patients.
    Heble DE; McPherson C; Nelson MP; Hunstad DA
    Pharmacotherapy; 2013 Dec; 33(12):1273-7. PubMed ID: 23798327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.